JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M206400200 on August 2, 2002

J. Biol. Chem., Vol. 277, Issue 42, 39209-39216, October 18, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/42/39209    most recent
M206400200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guaita, S.
Right arrow Articles by Baulida, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guaita, S.
Right arrow Articles by Baulida, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Snail Induction of Epithelial to Mesenchymal Transition in Tumor Cells Is Accompanied by MUC1 Repression and ZEB1 Expression*

Sandra GuaitaDagger §, Isabel PuigDagger §||, Clara FrancíDagger , Marta GarridoDagger , David DomínguezDagger , Eduard BatlleDagger **, Elena SanchoDagger **, Shoukat DedharDagger Dagger , Antonio García de HerrerosDagger §§, and Josep BaulidaDagger ¶¶

From the Dagger  Unitat de Biologia Cellular i Molecular, Institut Municipal d'Investigació Mèdica, Universitat Pompeu Fabra, E-08003 Barcelona, Spain and the Dagger Dagger  Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6H 3Z6, Canada

Received for publication, June 27, 2002, and in revised form, July 30, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

E-cadherin protein plays a key role in the establishment and maintenance of adherent junctions. Recent evidence implicates the transcription factor Snail in the blockage of E-cadherin expression in fibroblasts and some epithelial tumor cells through direct binding to three E-boxes in the E-cadherin promoter. Transfection of Snail into epithelial cells leads to a more fibroblastic phenotype. Cells expressing Snail presented a scattered flattened phenotype with low intercellular contacts. Other epithelial markers like Cytokeratin 18 or MUC1 were also repressed. The effects of Snail on MUC1 transcription were mediated by two E-boxes present in the proximal promoter. Snail also induced expression of the mesenchymal markers fibronectin and LEF1 and the transcription repressor ZEB1. ZEB1 and Snail had a similar pattern of expression in epithelial cell lines, and both were induced by overexpression of ILK1, a kinase that causes the loss of E-cadherin and the acquisition of a fibroblastic phenotype. Snail overexpression in several cell lines raised ZEB1 RNA levels and increased the activity of ZEB1 promoter. ZEB1 could also repress E-cadherin and MUC1 promoters but less strongly than Snail. However, since ZEB1 expression persisted after Snail was down-regulated, ZEB1 may regulate epithelial genes in several tumor cell lines.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The poor prognosis in epithelial neoplasia is associated with the acquisition of motile or invasive properties by the cancerous cells. This morphological transformation is often referred to as epithelial mesenchymal transition (EMT).1 EMT was first described in development when it is closely regulated and associated with processes like gastrulation or neuroepithelium formation. Molecular events during EMT include alterations in cell-cell adhesion, cell-substrate interaction, extracellular matrix degradation, and cytoskeleton organization. During EMT, epithelial markers are down-regulated, among them E-cadherin, a protein essential for the establishment of cell-cell adhesion (for review, see Refs. 1-3).

In cancerous cells there is a high correlation between invasion and metastasis and the loss of E-cadherin (4, 5), whereas during gastrulation E-cadherin is down-regulated in progenitor cells in the primitive streak (6). Control of E-cadherin transcription is the main mechanism responsible for the down-regulation of this protein (7, 8). A transcriptional factor called Snail (SNA in humans and Sna in mice) represses E-cadherin transcription in vitro and in vivo by binding to a 5'-CACCTG-3' sequence of the E-cadherin promoter (9). Transfection of Snail in epithelial cells decreases E-cadherin levels and induces changes resembling EMT (9, 10). In addition, Snail is believed to contribute to the EMT in several experimental models. For instance, during Drosophila gastrulation, Snail function is required for the repression in the mesoderm of genes that are otherwise expressed in the adjacent neuroectodermal regions of the blastoderm (11). Further evidence was obtained from Sna -/- mouse embryos, which show an incomplete EMT: a new mesoderm is formed, but the resulting cells maintain epithelial markers like E-cadherin (12). Other mutants that show defects in EMT and cell migration during gastrulation are fibroblast growth factor receptor 1 (-/-) animals; these defects have been attributed to a severe reduction of Snail expression in the primitive streak accompanied by ectopic expression of E-cadherin (13). Several conditions also induce EMT in epithelial cell lines (3). Snail is involved in a number of processes: for instance, activation of integrin-linked kinase (ILK), which mediates extracellular matrix signals (14, 15), increases Snail promoter activity and down-regulates E-cadherin (16). Finally, increased Snail expression has been described in some carcinogenic cell lines with invasive capacity (10, 17-19).

In this study we have examined with greater detail the changes induced by the ectopic expression of Sna in epithelial cells. In addition to showing the ultrastructural modifications observed in cells expressing Sna, we have also characterized several genes that show an altered expression. One of these genes is ZEB1,2 a transcriptional repressor also capable of blocking the expression of E-cadherin. The data obtained together with data previously reported clearly show that Snail induces a complete EMT.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell Culture-- The generation of Madin-Darby canine kidney (MDCK) cells and HT-29 M6 cells transfected with Sna-HA has been described (9). HT-29 M6 SNA1 and SNA2 correspond to two clones obtained by transfection with a tet-regulated expression vector (tet-off) containing hemagglutinin-tagged mouse Snail cDNA (Sna). MDCK SNA1 and SNA3 are two MDCK Sna-expressing clones obtained by transfection of MDCK cells with pIRES-neo Sna-HA (9). IEC-18 rat cells transfected with wild-type or negative forms of ILK or with an antisense construction of this kinase were obtained as described previously (14). Other human (HT-29, SW-480, SW-620, ZR-75, T47D, MCF-7, MiaPaca, and RWP-1) or mouse (EpH4 and NIH-3T3) cell lines were obtained from our institute Cell Bank. All cells were grown in Dulbecco's modified Eagle's medium (Invitrogen) containing 10% fetal calf serum (Biological Industries) and the standard supplements.

DNA Constructions and Other Reagents-- Murine ZEB1 cDNA was provided by T. Genetta (Children's Hospital of Philadelphia, Philadelphia, PA) and cloned into pcDNA3HisC expression vector (Promega) at the EcoRI site. ZEB2-CS2MT expression vector was kindly provided by A. Postigo (Washington University, St. Louis, MO). Sna-HA was cloned into RSV 5 expression vector inserting the 0.9-kb HindIII-NotI fragment from pcDNA3 Sna-HA at the XhoI site of RSV 5. Blunt ends were generated using the Klenow fragment from DNA polymerase (New England Biolabs). Commercial anti-ZEB1 was obtained from Santa Cruz Biotechnology (goat anti-ZEB1 C-20, sc-10570) and monoclonal anti-E-cadherin from Transduction Laboratories (c20820). Antiserum against recombinant mouse Snail was raised in New Zealand rabbits by standard protocols and purified by affinity chromatography using recombinant murine Snail.

Semithin Sections and Electron Microscopy-- Postconfluent cells were fixed in 2% glutaraldehyde for 30 min and embedded in EPON (Tousimis Research Corp., Rockville, MD). Semithin and ultrathin sections were obtained and stained using standard procedures. For electron microscopy, ultrathin sections were observed using a Philips CM100 electron microscope.

Analysis of Transcripts-- Northern blots were performed following a standard protocol. Briefly, 12.5 µg of total RNA isolated by guanidinium isothiocyanate extraction were separated in a denaturing agarose/formaldehyde gel, visualized with ethidium bromide staining, photographed, and transferred to a Zeta-probe (Bio-Rad) membrane overnight by capillarity action. The next day RNA was cross-linked to the membrane using a GS Gene linker (Bio-Rad) and hybridized with radiolabeled [alpha -32P]dCTP probes (rediprime II, Amersham Biosciences) using ExpressHyb solution (CLONTECH). MUC1 DNA probe was prepared from 50 ng of purified MUC1 cDNA cytosolic sequence, amplified by reverse transcription coupled to polymerase chain reaction (RT-PCR) from HT-29 M6 total RNA using the oligonucleotides 5'-CGAAAGCTTGCCGCCGAAAGAACTACG-3' (sense, 556-574) and 5'-GAGGATATCGCAAGTTGGCAGAAGTGGC-3' (antisense, 748-765) corresponding to a sequence stored in the GenBankTM (accession number X80671). Specific bands were visualized by autoradiography using Hyperfilm MP (Amersham Biosciences).

RT-PCR analysis from 0.5-1 µg of isolated total RNA was performed using SuperScript One-Step RT-PCR with Platinum Taq polymerase (Invitrogen). The following pairs of primers (sense/antisense) were used: hsZEB1, 5'-TTCAGCATCACCAGGCAGTC-3' (947-966)/5'-GAGTGGAGGAGGCTGAGTAG-3' (1663-1683); hsZEB2, 5'-GCTACGACCATACCCAGGAC-3' (2756-2776)/5'-TCTCGCCCGAGTGAAGCC-3' (3139-3157); Sna, 5'-GGCGGATCCACCATGCCGCGCTCCTTCCTGGTC-3' (1-24)/5'-CCGGATATCCGCGAGGGCCTCCGGAGCA-3' (778-791); SNA, 5'-TTCCAGCAGCCCTACGACCAG-3' (104-125)/5'-GCCTTTCCCACTGTCCTCATC-3' (290-310); hs Cyclophilin A: 5'-ATGGTCAACCCCACCGTG-3' (45-62)/5'-TGCAATCCAGCTAGGCATG-3' (690-708); hs Fibronectin, 5'-GTGCCTGGGCAACGGA-3' (922-938)/5'-CCCGACCCTGACCGAAG-3' (1554-1571); hs Cytokeratin 18, 5'-CTGGAGACCGAGAACCGGA-3' (352-370)/5'-tccgagccagctcgtcaT-3' (818-835); hsMUC1, 5'-catgGTACCGCAAGGCTCCCGGTGACC-3' (556-574)/5'-CGTAAGCTTGGGAGGGGGCAGAACAGATT-3' (748-765); hs E-cadherin, 5'-TTCCTCCCAATACATCTCCCTTCACAGCAG-3' (1977-2006)/5'-CGAAGAAACAGCAAGAGCAGCAGAATCAGA-3' (2287-2316); and hsLEF1, 5'-CTGCGCCACGGACGAG-3' (704-720)/5'-GAGAGGATGGACCGCATGG-3' (1098-1116). The sense and antisense primers anneal with different exons. The number of cycles and annealing temperatures were: ZEB1, 40 at 53 °C; ZEB2, 28 at 55 °C; SNA, 32 at 60 °C; Sna, 39 at 60 °C; hsMUC1, 30 at 60 °C; hs E-cadherin, 29 at 55 °C; hs Fibronectin, 30 at 55 °C; hsLEF1, 35 at 55 °C; hs Cytokeratin 18, 40 at 55 °C; and hs Cyclophilin A, 22 at 60 °C. The sequences indicated correspond to those stored in the GenBankTM under the following accession numbers: hsZEB1, U12170; hsZEB2, AB011141; SNA, NM005985; Sna, M95604; hsMUC1, X80671; hs E-cadherin, AB025106; hs Fibronectin, X02761; hsLEF1, AF288571; hs Cytokeratin 18, M26326; and hs Cyclophilin A, BC005320.

Cloning of MUC1 and ZEB1 Promoters-- The human MUC1 promoter sequence containing -756 to +49 bp from the transcription start site was cloned by PCR from HT-29 genomic DNA using high fidelity Taq polymerase (Pfx, Invitrogen) and oligonucleotides 5'-catgGTACCGCAAGGCTCCCGGTGACC-3' (2114-2133) and 5'-CGTAAGCTTGGGAGGGGGCAGAACAGATT-3' (2900-2919) corresponding to GenBankTM sequence X69118 containing KpnI and HindIII restriction sites at the ends. Purified PCR product was cloned into the KpnI and HindIII sites of a mutated version (9) of pGL3 Luciferase vector (Promega) (a putative Snail binding site of the plasmid was eliminated). A MUC1 promoter mutant in the two E-boxes, E-MUC (MUT), was obtained using the QuikChangeTM site-directed mutagenesis kit (Stratagene, La Jolla, CA). The sense oligonucleotide sequence was 5'-GAGGGGGCGGGGTTTTGTAAACCTATAACCTACTCGCTGTGCCTAGGGCCG-3', where mutated nucleotides are indicated in bold.

Human ZEB1 promoter (-361 to -53 from the translation start) was amplified from the same source using oligonucleotides 5'-CCGCCGAGCCTCCAACTTTA-3' (3119980-3119998) and 5'-CCTTCCCCCCCACCCCTCC-3' (3120269-3120287) corresponding to NCBI contig number NT_033982, containing MluI and HindIII sites at the 5'-ends, respectively. The fragment was cloned into the mutated version of pGL3 at the MluI and HindIII sites. All constructs were confirmed by sequencing.

Analysis of Promoter Activity-- Repression of E-cadherin or MUC1 promoter activity was measured by cotransfecting ZEB or Sna constructions in pcDNA3 plasmid (Invitrogen) with pGL3-E-cadherin or -MUC1 promoters in the indicated cell lines. Cotransfections included a Renilla reniformis luciferase plasmid (pRTK-Luc or pRSV-Luc from Promega) to normalize transfection efficiency. Firefly luciferase (Luc) and Renilla luciferase activities were measured using the Dual Luciferase Reporter Assay System (Promega) 48 h after transfection according to the manufacturer's instructions. Luc activity was normalized by Renilla luciferase activity. In all experiments, the total amount of DNA transfected was standardized with empty vector. Duplicates or triplicates were systematically included, and experiments were repeated at least three times. ZEB1 or MUC1 promoter activity in Sna clones was assayed by cotransfecting varying amounts of pGL3-ZEB1 or -MUC1 promoter reporter and pRTK-Luc and measuring luciferase activity as mentioned above.

Analysis of Protein Expression-- Cells were seeded on 1-cm-diameter cover glasses, left to grow to 40-70% confluence, fixed with 4% paraformaldehyde, blocked with 5% milk in phosphate-buffered saline, and incubated with specific antibodies. Fluorescein isothiocyanate-conjugated anti-goat or anti-rabbit (DAKO) was used as second antibody. Immunofluorescent labeled cells were observed in a fluorescent microscope (Axioskop). Alternatively, protein expression was determined by Western blot using 15 µg of lysates obtained by boiling the cells in 1% SDS.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The fibroblastoid morphology of several of the Sna-transfected HT-29 M6 and MDCK cell clones used in this work is shown in Fig. 1. The main attribute of these cells is the failure to form compacted colonies and a more scattered aspect. In HT-29 M6 clones transfected with the tet-off system, the epithelial phenotype was restored by addition of the tetracycline analogue doxycycline, which prevents expression of Snail (Fig. 1 and Ref. 9).


View larger version (74K):
[in this window]
[in a new window]
 
Fig. 1.   Morphology of HT-29 M6 and MDCK clones transfected with Sna. Photographs were taken at ×200 (MDCK) or ×320 (HT-29 M6) magnification of cell lines expressing Sna. When indicated (+tet), HT-29 M6 Sna clones were grown in the presence of doxycycline (2 µg/ml). CONT, control.

Lateral sections obtained from HT-29 M6 clones illustrate that Snail overexpression prevented the formation of the compact columnar epithelial-like monolayer characteristic of HT-29 M6 cells and reduced the thickness from 12-16 to 4-6 µm (Fig. 2, left panels). HT-29 M6 SNA1 clone, like the other Sna-expressing clones, showed a flattened, fibroblast-like phenotype with cells disposed occasionally on the top of others. No cell contacts were observed in these transfectants in contrast to control HT-29 M6 clones where tight junctions, adherens junctions, and desmosomes were seen (Fig. 2, right panels). These control clones also showed closer apposition of lateral membranes and other characteristics of well differentiated epithelial cells like microvilli and mucus droplets.


View larger version (78K):
[in this window]
[in a new window]
 
Fig. 2.   Semithin sections and electron microscopy of Sna-transfected HT-29 M6 cells. HT-29 M6 control and SNA1 clones were grown up to confluence. Semithin sections (left panels) and ultrathin sections visualized with an electron microscope (right panels) are shown. M, mucus droplets; MV, microvilli; TJ, tight junction; AJ, adherent junction; D, desmosome; N, nucleus; CON, control.

Some cell properties were also altered in the Sna transfectants, compatible with the transition from an epithelial to a mesenchymal phenotype. In addition to a decrease in intercellular adhesion (Figs. 1 and 2, and data not shown), Sna-expressing clones attached better to plastic and spread faster on several matrices such as collagen or laminin (data not shown). Increases in these two parameters are observed in fibroblasts with respect to well differentiated epithelial cells like HT-29 M6. HT-29 M6 Sna clones treated with doxycycline were indistinguishable from controls (not shown).

We also determined whether these changes in phenotype were accompanied by alterations in the expression of different genes. Using a semiquantitative RT-PCR analysis, we found RNA levels of several epithelial genes, other than E-cadherin, to be decreased in Sna-transfected clones of HT-29 M6 cells (Fig. 3). Expression of MUC1 and Cytokeratin 18, which contain putative Snail-binding sequences in their promoters (see below), decreased in Sna-transfected clones. On the other hand, Fibronectin, LEF1, and ZEB1 were up-regulated in Sna transfectants. Increased levels of Fibronectin have already been reported in MDCK cells transfected with Snail (10); the augmentation in the synthesis of this protein might be responsible for the higher rate of attachment and spreading of Sna clones. ZEB1 and LEF1 are two transcription factors related to mesenchymal phenotypes. LEF1 is the preferential LEF/T cell factor isoform in mesenchymal cells and is differentially expressed in some neoplastic processes such as colon cancers (20). On the other hand, ZEB1 is a transcriptional factor recently described to be involved in E-cadherin repression (21). To investigate the changes in gene expression that accompany this epithelial to mesenchymal transition we decided to analyze in greater detail the modulation of two representative genes: one, MUC1, that is repressed, and another one, ZEB1, that is activated.


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 3.   Sna-transfected clones display a down-regulation of epithelial and an induction of mesenchymal genes. RNA was obtained from HT-29 M6 control cells or SNA1 and SNA2 clones by standard procedures. One-step RT-PCR RNA amplifications were performed with 500 ng of total RNA, and products were separated in 1.5-2% agarose gels. Oligonucleotide primer sequences were specified under "Materials and Methods," and the sizes of the amplified fragments correspond to those expected. The first lane of each row corresponds to low range DNA molecular weight markers (MBI, Fermentas): 908, 659-656, 521, 403, 283, 257, and 226 bp.

MUC1 is a marker of several epithelial tissues including the colonic epithelium. Its promoter sequence contains a tandem repeat of the consensus Snail DNA binding sequence situated at -84 bp from the transcription start (22). Therefore, like E-cadherin, this gene is a putative direct target of Snail. Northern blots corroborated that MUC1 RNA levels were significantly lower in Sna-expressing HT-29 M6 clones than in controls (Fig. 4A). Then we analyzed whether the Snail-induced decrease of MUC1 RNA was a consequence of a repression of the activity of the promoter. An 800-bp MUC1 gene fragment, corresponding to sequence containing -756 to +49 with respect to the transcription start (22), was cloned and inserted into the pGL3 plasmid upstream of the luciferase reporter gene. This promoter has been described to be active in epithelial cell lines expressing MUC1 (22). MUC1 transcriptional activity was lower in the Sna transfectant clones than in control or parental cells (Fig. 4B). The Snail-induced repression of the MUC1 promoter was reproduced when Snail was transiently transfected in HT-29 M6 parental cells or other MUC1-expressing epithelial cells. In all cases, Snail repressed the activity of the promoter in a dose-dependent manner by up to 80% (Fig. 4C). This repression was not observed with the Sna mutant Pro-2 right-arrow Ala (data not shown), which does not block E-cadherin promoter activity (9). Modification of the putative Snail-binding element in the promoter (mutation of 5'-cacctgtcacctg-3' to 5'-aacctataaccta-3') prevented the decrease in MUC1 promoter activity (Fig. 4C). A similar mutation has been reported to inhibit binding of Snail to E-cadherin promoter E-boxes and repression of this promoter (9). Therefore, the presence of a Snail binding sequence is required to block MUC1 transcription. These results demonstrate that Snail represses directly the expression of at least another epithelial marker in addition to E-cadherin.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   Snail represses MUC1 gene expression. A, RNA obtained from control HT-29 M6 cells or SNA1 or SNA2 clones was analyzed by Northern blot using a radiolabeled MUC1 cDNA probe. Ethidium bromide-stained 18 S and 28 S bands were photographed before blotting and are shown as a loading control. The two bands detected in this analysis correspond to the two alleles of MUC1 in these cell lines (22). B, reporter assays on HT-29 M6 cells control, SNA1, and SNA2 were preformed as described using 400 ng of pGL3 or pGL3-MUC1 promoter and 25 ng of pRTK-Luc to normalize transfection efficiency. C, cell lines were transfected with 250-500 ng of pGL3-MUC1 promoter (wild type or with the E-box mutated) in the presence of 25 ng of pCDNA3-Sna or pCDNA3 as a control, and luciferase activity was determined as above. Values were normalized using Renilla luciferase activity (pRTK-Luc, 15-30 ng). Results represent percentage of maximal repression versus control pCDNA3 values. The results correspond to a representative experiment of three independent experiments performed in duplicate or triplicate. WT, wild type.

The induction of ZEB1 expression was also investigated. As mentioned above, ZEB1 is also a transcriptional repressor capable, like Snail, of preventing the activity of the E-cadherin promoter. First, the expression of these three genes (SNA/Sna, ZEB1, and E-cadherin) was analyzed in a collection of epithelial cell lines expressing variable amounts of E-cadherin. Because of the low amounts of transcription factor RNAs present in a total RNA preparation, we used RT-PCR to detect Sna and ZEB1. Only in those cell lines in which Snail and ZEB1 were coexpressed was E-cadherin severely down-regulated (Fig. 5, upper panels). In a few cell lines, like EpH4, we detected simultaneous expression of both E-cadherin and Snail but not ZEB1.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 5.   Snail and ZEB1 expression in epithelial cell lines. E-cadherin expression was analyzed by Western blot using SDS lysates from a set indicated cell lines (upper panel). RNA expression of human, rat, and mouse Snail, ZEB1, and ZEB2 was analyzed by RT-PCR as described (lower panel). Oligonucleotides used for ZEB amplification recognize human rat and murine forms; those used for murine Snail (mmSna) also amplified the rat (rn) cDNA. IEC-18, control IEC-18 cell line transfected with empty vector; ILK (KD), IEC-18 cells transfected with a kinase-dead form of ILK; ILK (AS), IEC-18 cells transfected with an antisense cDNA of ILK; ILK-13; IEC-18 cells transfected with an active form of ILK.

We also analyzed whether the expression of Snail is induced in conditions in which cells undergo EMT. We used as a model IEC-18 epithelial cells that undergo EMT when transfected with ILK (14). When an active ILK was expressed, IEC-18 cells acquired a fibroblastoid phenotype that correlated with a down-regulation of E-cadherin. Although Snail was detected in these cells, overexpression of ILK induced an increase in the RNA corresponding to this gene. We found that the active ILK form also induced ZEB1 RNA (Fig. 5, lower panels). Therefore, ZEB1 seems to be induced concomitantly with Snail and the acquisition of the fibroblastoid phenotype in IEC-18 cells.

The involvement of Snail in ZEB1 activation was evidenced by our data with Sna transfectants. As mentioned above (see Fig. 3), in our Sna-expressing HT-29 M6 clones ZEB1 RNA levels were increased. A more detailed study was performed in these clones taking advantage of the regulation of the expression of this gene by the tetracycline analogue doxycycline. ZEB1 RNA transcription was detected only after Snail RNA expression was turned on by withdrawing doxycycline from the medium (Fig. 6). Expression of Sna was detected 4 days after withdrawing doxycycline, slightly preceding ZEB1 expression, which required 8 days. Therefore Sna expression is sufficient to trigger the ZEB1 RNA up-regulation. On the other hand, when Sna expression was turned off by adding doxycycline, ZEB1 RNA did not disappear immediately, as did Sna, but diminished gradually. The stability of ZEB1 RNA in the absence of Snail suggests that ZEB1 could possibly prolong the repression of epithelial genes initiated by Snail.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 6.   Snail promotes ZEB1 expression in tetracycline-regulated Sna transfectants. Left panel, expression of ZEB1 and ZEB2 after induction of Sna. The SNA1 HT-29 M6 clone was culture in Dulbecco's modified Eagle's medium plus fetal calf serum (10%) in the presence of doxycycline (2 µg/ml) for 30 days. Induction of Sna was achieved by withdrawing doxycycline from the medium for the indicated days (D). Control cells were grown in the absence of doxycycline. Right panel, expression of ZEB1 and ZEB2 after repression of Sna. SNA1 HT-29 M6 cells were grown in the absence of doxycycline; expression of this gene was repressed by adding doxycycline to the growth medium for the indicated days. Sna, ZEB1, and ZEB2 RNA levels were analyzed by RT-PCR. D0 corresponds to the day when the doxycycline was added (right panel) or withdrawn (left panel). CON, control.

This result seems not to be exclusive of these HT-29 M6 clones since MDCK Sna-transfected clones also showed increased levels of ZEB1 RNA (Fig. 7A). The molecular mechanism by which Snail induces ZEB1 was studied. To test whether Snail induces the transcription of ZEB1, we cloned a 308-bp DNA fragment upstream of the ZEB1 first exon and assayed its promoter activity in MDCK control and Sna-expressing cells. Sna-expressing MDCK clones contained 2.5-fold higher activity than controls of this promoter (Fig. 7B), indicating that Snail increases ZEB1 RNA at least in part by the activation of the transcription of this gene. To validate this result we tested the reporter activity in transient transfection of Snail. In RWP-1 cells Snail also increased the transcriptional activity of the ZEB1 reporter; however, this effect was only observed when the activity was determined in cells transfected longer than 48 h (Fig. 7C).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7.   Snail induces ZEB1 promoter activity. A, RT-PCR analysis of Sna, ZEB1, and ZEB2 RNA in Sna-expressing MDCK clones. Canine ZEB1 and ZEB2 RNAs were amplified using oligonucleotides obtained from human ZEB sequences. B, activity of the ZEB1 promoter in MDCK control, SNA1, and SNA3 clones. Cells were transfected with pGL3 or pGL3-ZEB1 promoter for 48 h with 100 ng of plasmid and 5 ng of pRLSV-Luc to normalize transfection efficiency. C, activity of the ZEB1 promoter in RWP-1 transiently transfected with Sna. Cells were cotransfected with 100 ng of pGL3-ZEB1 promoter, 5 ng of pRLSV-Luc, and 10 or 50 ng of pRSV-Sna. Luciferase activity was assayed 3 or 6 days after transfection (d3 and d6, respectively). Results show the average ± range of two to three experiments performed in triplicate.

The ZEB1 homologue, ZEB2, has also been described to behave as an E-cadherin repressor (23). However, it did not respond to Snail activation in any of our experiments, and its expression did not correlate with that of Snail in the epithelial cell lines tested; it was detected in all the cell lines analyzed (Figs. 5 and 7A).

As the first step to confirm the putative role of ZEB1 as a repressor in the Snail activated pathway, we confirmed that ZEB1 protein was also up-regulated in Sna-transfected clones. A clear increase of this protein was detected in the nucleus in HT-29 M6 and MDCK clones (Fig. 8). We also analyzed the repression activity of ZEB1 on E-cadherin promoter transcription in several epithelial cell lines using a proximal E-cadherin promoter (-178 to +23) upstream of a luciferase gene reporter. This promoter sequence contains three 5'-CACCTG-3' boxes where Snail and ZEB1 can bind. ZEB1 repressed the promoter activity in a dose-dependent manner with a maximal inhibition of 60-80% in the cell lines tested, which included RWP-1 (Fig. 9A), MCF-7 (Fig. 9B), HT-29 M6, and MDCK (data not shown). The degree of repression obtained with ZEB1 and Snail were comparable; however, although both were expressed under the same promoter, ZEB1 required a 10-20-fold higher dose to achieve the maximum repression in the four cell lines assayed. This effect on the E-cadherin promoter was accompanied by changes in the expression of this protein (not shown). Thus, ZEB1 also holds the potential to repress E-cadherin transcription, although less effectively than Snail. On the other hand, ZEB2 repressed the promoter poorly with a maximum of 40% in MCF-7 cells (Fig. 9B). No synergistic effects were observed in experiments of simultaneous repression of Sna and ZEB1 on E-cadherin promoter; inhibitions of the activity of this promoter by both factors are additive (Fig. 9A).


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 8.   Nuclear localization of Snail-induced ZEB1. HT-29 M6 (control and SNA1 clone) and MDCK (control and SNA1 clone) cells were stained with polyclonal antibodies against Sna (1:10 dilution) or ZEB1 (1:50 dilution) as described under "Materials and Methods." Expression was determined in a fluorescent microscope. CONT, control.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 9.   Epithelial repression activity of ZEB1 and Snail. Cells were cotransfected with 250 ng of pGL3-E-cadherin promoter (A and B) or pGL3-MUC1 promoter (C), 5 ng of pRLSV-Luc, and the indicated amounts of Sna, ZEB1, or ZEB2 in pcDNA3. In all experiments luciferase activity was assayed 48 h after transfection and normalized taking into account the value obtained with Renilla luciferase. Results show the average ± range of three to four experiments performed in triplicate.

We also tested whether ZEB1 repressed another Snail target gene, MUC1. Reporter assays using the above-described MUC1 promoter show that, in a fashion similar to Snail, ZEB1 repressed the promoter activity (Fig. 9C). Similar to the results obtained with E-cadherin promoter, ZEB1 was at least 10-fold less potent than Snail as a repressor of the MUC1 promoter.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In certain circumstances epithelial cells can undergo extensive changes in their phenotype and convert to mesenchymal cells. This EMT is observed in several phases of embryonic development and in carcinoma cell invasion and metastasis. Transcription of E-cadherin gene is down-regulated during these processes (4, 5). However, EMT involves a decrease of a set of epithelial tissue-specific molecules or markers other than E-cadherin and an increase of mesenchyme-related molecules (1). We (9) and others (10) have reported that the transcriptional repressor Snail blocks E-cadherin expression by binding to specific E-boxes in its promoter, but the mechanism by which levels of other molecules are regulated in EMT is poorly understood. Genetic approaches in Drosophila have showed that two transcription factors, Snail and Twist, regulate the expression of mesenchymal and epithelial genes, although some mesenchymal genes can also be regulated by other transcriptional genes like Dorsal and Tailless (11). Developmental studies (for review, see Ref. 24) as well as data obtained after transfection to epithelial cells indicate that Sna induces a complete EMT when transfected to cultured epithelial cells. We took advantage of this capacity of Sna to study the mechanisms of repression of epithelial genes or activation of mesenchymal genes.

Epithelial genes other than E-cadherin, like MUC1 and Cytokeratin 18, also possess E-boxes on their promoters. Our results show that RNA levels of these genes are decreased after Snail expression (Figs. 3 and 4) and that repression of MUC1 requires intact E-boxes (Fig. 4). Therefore, MUC1 and E-cadherin seem to be regulated by a common mechanism that involves Snail. However, other factors with affinity for this sequence may also participate in the down-regulation of MUC1 and E-cadherin transcription.

Among the genes up-regulated by Snail we found a transcriptional repressor, ZEB1, also capable of binding the same E-boxes as Snail. ZEB1 and ZEB2 are homologues of Drosophila Zfh-1, which is active downstream of Snail in embryonic development. Snail is required for the expression of Zfh-1 in the mesoderm primordium; in Snail mutants, Zfh-1 expression is severely reduced (25). Our results obtained from Sna-inducible and stable clones clearly show that Snail increases ZEB1 RNA (Figs. 5-7) and protein levels (Fig. 8) during EMT. We have also shown, through reporter experiments, that ZEB1 augmentation is due, at least in part, to an elevation of the transcriptional activity of the ZEB1 promoter (Fig. 9B). Although the ZEB1 promoter contains E-box sequences, we do not think that Snail directly activates ZEB1 promoter since (a) the time required to observe the increase of the reporter is longer than the time required to repress E-cadherin or MUC1 promoters (compare Figs. 7C and 9) and (b) ZEB1 expression was detected after 4 days of expression of Snail in a Sna-inducible clone (Fig. 6B).

ZEB1, like Snail, represses E-cadherin and MUC1 transcription when transfected into epithelial cells. Moreover, tumor cell lines with severe reduction of E-cadherin expressed both Snail and ZEB1 (Fig. 3), and Snail and ZEB1 repression activities were additive (Fig. 9). In addition to the up-regulation of ZEB1 RNA in Snail-induced clones, when Snail expression was switched off, ZEB1 expression required more than 20 days to gradually return to basal levels (Fig. 6). This observation indicates that in circumstances of a transient expression of Snail, ZEB1 prolonged Snail-induced repression of epithelial genes. In agreement with this hypothesis, in Drosophila embryos Zfh-1 persists after Snail is down-regulated (26, 27). However, whereas Sna knock-out mutant mice are not viable due to defective gastrulation (12), ZEB1 is dispensable for this process. ZEB1 knock-out animals develop to term, although they show severe deficiencies in T cell production in the thymus and several skeletal defects (28). Therefore, Snail, but not ZEB1, is necessary for the E-cadherin down-regulation required for a correct gastrulation.

The analysis of tumor cell lines with different epithelial or mesenchymal characteristics as well as IEC-18 intestinal cells expressing ILK showed a high inverse relationship between ZEB1 and E-cadherin expression. This relationship is better than that presented by E-cadherin and Snail since we detected several cell lines expressing these two proteins. However, recent data from our laboratory indicates that the presence of Snail does not always correlate with the activity of this factor since in several cell lines, in those that present concomitant expression of E-cadherin, Snail protein is excluded from the nucleus.3 These data, together with those obtained with knock-out mice, suggest that Snail is the key element controlling E-cadherin transcription and triggering EMT and, therefore, ZEB1 expression in most of epithelial cell lines. However, in some tumors, ZEB1 might become unresponsive to Snail activation as a result of mutations in the promoter or the activation of some of its transcriptional activators and might block E-cadherin expression.

All cell lines tested showed expression of ZEB2 independently of Snail and E-cadherin levels. This expression of ZEB2 was not modified either during ILK-induced EMT of IEC-18 cells or after induction of Snail. These observations strongly suggest a different regulation for the expression of the two ZEB homologues: ZEB1 is induced by Snail and is specific to fibroblastic cells, whereas ZEB2 is constitutively expressed in all the cell lines, independently of their epithelial or mesenchymal lineage. Moreover, although ZEB2 induces repression of E-cadherin promoter in some cellular contexts (Ref. 23 and Fig. 9B), this factor presents much lower activity than ZEB1 or Snail. The difference in the repression of E-cadherin between ZEB1 and ZEB2 may be due to the distinct organization of the regulatory domains (29). In any case, our results indicate that the endogenous amount of ZEB2 cannot repress the activity of basal epithelial promoters in tumor cells. However, due to its ubiquitous expression, the question of whether ZEB2 cooperates with Snail to repress epithelial promoters remains to be answered.

    ACKNOWLEDGEMENTS

We thank Drs. Postigo and Genetta for kindly providing reagents. The technical support of Judit Grueso and M. Carmen Torns is greatly appreciated. We also thank Dr. J. Lloreta for help with electronic microscopy.

    FOOTNOTES

* This work was supported by Ministerio de Ciencia y Tecnología Grant PM99-0132 (to A. G. H.) and Fondo de Investigaciones Sanitarias Grant 01/3060 (to J. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors made equivalent contributions to this work.

Recipient of a predoctoral fellowship from Ministerio de Ciencia y Tecnología (Formación de Personal Investigador) and supported by a predoctoral fellowship "Xavier Lamas" awarded by Institut Municipal d'Assistència Sanitària for the initial work.

** Current address: Dept. of Immunology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands.

|| Recipient of a predoctoral fellowship from Ministerio de Educación (Formacion del Profesorado Universitario).

§§ To whom correspondence may be addressed: Institut Municipal d'Investigació Mèdica, c/Doctor Aiguader, 80, E-08003 Barcelona, Spain. Tel.: 34-93-221-1009; Fax: 34-93-221-3237; E-mail: agarcia@imim.es.

¶¶ To whom correspondence may be addressed: Institut Municipal d'Investigació Mèdica, c/Doctor Aiguader, 80, E-08003 Barcelona, Spain. Tel.: 34-93-221-1009; Fax: 34-93-221-3237; E-mail: jbaulida@imim.es.

Published, JBC Papers in Press, August 2, 2002, DOI 10.1074/jbc.M206400200

2 In this study we use the name ZEB1 to refer to the gene that has also been called ZEB, AREB6 (in humans), BZP (in hamster), or delta EF1 (in chicken) (GenBankTM accession number U12170) and ZEB2 for the gene also known as SIP1 (GenBankTM accession number AB011141).

3 D. Domínguez, B. Montserrat, J. Grueso, M. Porta, A. Virgós, C. Francí, J. Baulida, and A. García de Herreros, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: EMT, epithelial to mesenchymal transition; ILK, integrin-linked kinase; LEF, lymphoid enhancer factor; RT, reverse transcription; SNA, human Snail gene, Sna, mouse Snail gene; MDCK, Madin-Darby canine kidney; HA, hemagglutinin; RSV, Rous sarcoma virus; hs, Homo sapiens; Luc, firefly luciferase; tet, tetracycline.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Hay, E. D. (1995) Acta Anat. (Basel) 154, 8-20
2. Boyer, B., Vallés, A. M., and Edme, N. (2000) Biochem. Pharmacol. 60, 1091-1099[CrossRef][Medline] [Order article via Infotrieve]
3. Savagner, P. (2001) Bioessays 23, 912-923[CrossRef][Medline] [Order article via Infotrieve]
4. Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W., and van Roy, F. (1991) Cell 66, 107-119[CrossRef][Medline] [Order article via Infotrieve]
5. Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H., and Christofori, G. A. (1998) Nature 392, 190-193[CrossRef][Medline] [Order article via Infotrieve]
6. Oda, H., Tsukita, S., and Takeichi, M. (1998) Dev. Biol. 203, 435-450[CrossRef][Medline] [Order article via Infotrieve]
7. Hennig, G., Lowrick, O., Birchmeier, W., and Behrens, J. (1996) J. Biol. Chem. 271, 595-602[Abstract/Free Full Text]
8. Ji, X., Woodard, A. S., Rimm, D. L., and Fearon, E. R. (1997) Cell Growth Differ. 8, 773-778[Abstract]
9. Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., and García de Herreros, A. (2000) Nat. Cell Biol. 2, 84-89[CrossRef][Medline] [Order article via Infotrieve]
10. Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., and Nieto, M. A. (2000) Nat. Cell Biol. 2, 76-83[CrossRef][Medline] [Order article via Infotrieve]
11. Casal, J., and Leptin, M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 10327-10332[Abstract/Free Full Text]
12. Carver, E. A., Jiang, R., Lan, Y., Oram, K. F., and Gridley, T. (2001) Mol. Cell. Biol. 21, 8184-8188[Abstract/Free Full Text]
13. Ciruna, B., and Rossant, J. (2001) Dev. Cell 1, 37-49[CrossRef][Medline] [Order article via Infotrieve]
14. Hannigan, G. E., Leung-Hagesteijn, C., Fitz-Gibbon, L., Coppolino, M. G., Radeva, G., Filmus, J., Bell, J. C., and Dedhar, S. (1996) Nature 379, 91-96[CrossRef][Medline] [Order article via Infotrieve]
15. Dedhar, S. (2000) Curr. Opin. Cell Biol. 12, 250-256[CrossRef][Medline] [Order article via Infotrieve]
16. Tan, C., Costello, P., Sanghera, J., Domínguez, D., Baulida, J., García de Herreros, A., and Dedhar, S. (2001) Oncogene 20, 133-140[CrossRef][Medline] [Order article via Infotrieve]
17. Poser, I., Dominguez, D., Garcia de Herreros, A., Varnai, A., Buettner, R., and Bosserhoff, A. K. (2001) J. Biol. Chem. 276, 24661-24666[Abstract/Free Full Text]
18. Cheng, C. W., Wu, P. E., Yu, J. C., Huang, C. S., Yue, C. T., Wu, C. W., and Shen, C. Y. (2001) Oncogene 20, 3814-3823[CrossRef][Medline] [Order article via Infotrieve]
19. Jiao, W., Miyazaki, K., and Kitajima, Y. (2002) Br. J. Cancer 7, 98-101
20. Hovanes, K., Li, T. W., Munguia, J. E., Truong, T., Milovanovic, T., Lawrence-Marsh, J., Holcombe, R. F., and Waterman, M. L. (2001) Nat. Genet. 28, 53-57[CrossRef][Medline] [Order article via Infotrieve]
21. Grooteclaes, M. L., and Frisch, S. M. (2000) Oncogene 19, 3823-3828[CrossRef][Medline] [Order article via Infotrieve]
22. Kovarik, A., Peat, N., Wilson, D., Gendler, S. J., and Taylor-Papadimitriou, J. (1993) J. Biol. Chem. 268, 9917-9926[Abstract/Free Full Text]
23. Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., and van Roy, F. (2001) Mol. Cell 7, 1267-1278[CrossRef][Medline] [Order article via Infotrieve]
24. Nieto, M. A. (2002) Nat. Rev. Mol. Cell Biol. 3, 155-166[CrossRef][Medline] [Order article via Infotrieve]
25. Lai, Z. C., Fortini, M. E., and Rubin, G. M. (1991) Mech. Dev. 34, 123-134[CrossRef][Medline] [Order article via Infotrieve]
26. Leptin, M. (1991) Genes Dev. 5, 1568-1576[Abstract/Free Full Text]
27. Gray, S., and Levine, M. (1996) Genes Dev. 10, 700-710[Abstract/Free Full Text]
28. Takagi, T., Moribe, H., Kondoh, H., and Higashi, Y. (1998) Development 125, 21-31[Abstract]
29. Postigo, A. A., and Dean, D. C. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 6391-6396[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
N. Herranz, D. Pasini, V. M. Diaz, C. Franci, A. Gutierrez, N. Dave, M. Escriva, I. Hernandez-Munoz, L. Di Croce, K. Helin, et al.
Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor
Mol. Cell. Biol., August 1, 2008; 28(15): 4772 - 4781.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G. Solanas, M. Porta-de-la-Riva, C. Agusti, D. Casagolda, F. Sanchez-Aguilera, M. J. Larriba, F. Pons, S. Peiro, M. Escriva, A. Munoz, et al.
E-cadherin controls {beta}-catenin and NF-{kappa}B transcriptional activity in mesenchymal gene expression
J. Cell Sci., July 1, 2008; 121(13): 2224 - 2234.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. R. Graham, H. E. Zhau, V. A. Odero-Marah, A. O. Osunkoya, K. S. Kimbro, M. Tighiouart, T. Liu, J. W. Simons, and R. M. O'Regan
Insulin-like Growth Factor-I-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
Cancer Res., April 1, 2008; 68(7): 2479 - 2488.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. Beltran, I. Puig, C. Pena, J. M. Garcia, A. B. Alvarez, R. Pena, F. Bonilla, and A. G. de Herreros
A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition
Genes & Dev., March 15, 2008; 22(6): 756 - 769.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
Y. Liu, S. El-Naggar, D. S. Darling, Y. Higashi, and D. C. Dean
Zeb1 links epithelial-mesenchymal transition and cellular senescence
Development, February 1, 2008; 135(3): 579 - 588.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Olmeda, G. Moreno-Bueno, J. M. Flores, A. Fabra, F. Portillo, and A. Cano
SNAI1 Is Required for Tumor Growth and Lymph Node Metastasis of Human Breast Carcinoma MDA-MB-231 Cells
Cancer Res., December 15, 2007; 67(24): 11721 - 11731.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Konopka, J. Tekiela, M. Iverson, C. Wells, and S. A. Duncan
Junctional Adhesion Molecule-A Is Critical for the Formation of Pseudocanaliculi and Modulates E-cadherin Expression in Hepatic Cells
J. Biol. Chem., September 21, 2007; 282(38): 28137 - 28148.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Wang, C. Sloss, X. Zhang, S. W. Lee, and J. C. Cusack
Membrane-Bound Heparin-Binding Epidermal Growth Factor Like Growth Factor Regulates E-Cadherin Expression in Pancreatic Carcinoma Cells
Cancer Res., September 15, 2007; 67(18): 8486 - 8493.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Wang, M. Zheng, G. Liu, W. Xia, P. J. McKeown-Longo, M.-C. Hung, and J. Zhao
Kruppel-Like Factor 8 Induces Epithelial to Mesenchymal Transition and Epithelial Cell Invasion
Cancer Res., August 1, 2007; 67(15): 7184 - 7193.
[Abstract] [Full Text] [PDF]